More than 50 articles have been published on clinical markers, such as anemia, mineral bone disease, quality of life, and serum biomarkers, such as FGF23, adiponectin, and hepcidin, of CKD in the Korean population using the KNOW-CKD cohort10. This evidence concerns the gene HAMP and chronic kidney disease.